Technology

Laser Photonics Jumps 121% on Anti-Drone System's Defense Review Selection

Laser Photonics shares surged 121% after its anti-drone system was selected for a key U.S. defense technical review, but no contract or sales were announced, and the company faces a Nasdaq compliance notice.

Sarah Chen · · 3 min read · 1 views
Laser Photonics Jumps 121% on Anti-Drone System's Defense Review Selection
Mentioned in this article
LASE $0.93 +0.91%

Laser Photonics (LASE) experienced a dramatic surge in share price on Tuesday, soaring 121% after the company announced that its Laser Shield Anti-Drone (LSAD) system had been selected for a U.S. defense technical review. The news ignited heavy trading volume in the small-cap stock, which has been under pressure due to recent filing delays.

The stock opened at $1.20 and climbed to $2.05 by 12:49 p.m. EDT, with an intraday range between $0.925 and $2.18. Trading volume reached approximately 120.9 million shares, far exceeding typical levels, according to market data.

Defense Review Details

Laser Photonics stated that its LSAD system was chosen as part of the Mission Engineering and Integration Activity Vulcan Call for Solutions, where it was listed as a top entry in the Counter C5ISR-T category. This category encompasses command, control, communications, computers, cyber, intelligence, surveillance, reconnaissance, and targeting—essentially the technology that enables military forces to observe, decide, and act.

CEO Wayne Tupuola commented that the selection "validates the mission relevance and readiness" of the company's directed-energy technology, which uses focused laser beams instead of traditional projectiles. The next step involves a direct technical exchange with government engineers to assess validation, scalability, and mission fit. Systems that pass this stage may proceed to follow-on prototyping or receive support for experimentation and transition.

No Contract or Revenue Yet

Despite the positive news, Laser Photonics emphasized that this is a technical review and not a booked order. There was no mention of a contract win or any new sales in the company's announcement. The rally appears driven by speculation, as the company remains a small player in the defense sector.

Laser Photonics reported total net sales of $8.3 million for 2025, an increase driven by acquisitions and industrial demand, but it ended the year with a net loss of $17.5 million. The company faces significant financial challenges, and the defense review does not guarantee future revenue.

Competitive Landscape

The counter-drone market is becoming increasingly crowded. AeroVironment recently showcased its Locust X3 anti-drone laser, with Vice President John Garrity noting that militaries are "losing the economics of warfare" by using expensive interceptors against low-cost drones. Meanwhile, Australia-based Electro Optic Systems is expanding its high-energy anti-drone laser business and has opened a production center in Singapore, targeting customers in the Netherlands and Korea. CEO Andreas Schwer highlighted growing demand for affordable drone defense solutions.

Nasdaq Compliance Issue

Laser Photonics is also dealing with a compliance problem on the Nasdaq exchange. According to a May 22 SEC filing, the company received a notice for failing to file its Form 10-Q for the quarter ending March 31, 2026. The exchange has set a 60-day deadline for Laser Photonics to submit a compliance plan, with a possible extension until November 16, 2026.

While traders are currently focused on the anti-drone news, the key question remains whether Laser Photonics can transition from a technical review to a funded program while resolving its reporting issues. The rally may be pricing in more than what is currently on the table, as defense contracts often involve lengthy testing phases before any significant revenue materializes.

This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Market data may be delayed. Always conduct your own research and consult a licensed financial advisor before making investment decisions.